Skip to content
  • About Us
    • About Evonexus
    • Portfolio Job Board
    • Locations
      • Irvine
      • San Diego
  • People
  • Partners
  • Portfolio
  • Incubation
    • General EvoNexus Incubation
  • Events
    • Special Interest Groups (SIGs)
    • Demo Day
  • News
  • About Us
    • About Evonexus
    • Portfolio Job Board
    • Locations
      • Irvine
      • San Diego
  • People
  • Partners
  • Portfolio
  • Incubation
    • General EvoNexus Incubation
  • Events
    • Special Interest Groups (SIGs)
    • Demo Day
  • News
  • Partner
  • People
  • Company
    • About
    • Portfolio Companies
    • Portfolio Job Board
    • Locations
      • Irvine
      • San Diego
  • Incubation
    • General EvoNexus Incubation
  • Events
    • Special Interest Groups (SIGs)
    • Demo Day
  • Apply Now
  • Partner
  • People
  • Company
    • About
    • Portfolio Companies
    • Portfolio Job Board
    • Locations
      • Irvine
      • San Diego
  • Incubation
    • General EvoNexus Incubation
  • Events
    • Special Interest Groups (SIGs)
    • Demo Day
  • Apply Now
Apply Now

Day: August 6, 2018

Nanomedical Diagnostics Agile R100 Graphene Biosensor Characterizes Difficult-to-Study MYC Oncoprotein for Cancer Research

Nanomedical Diagnostics Agile R100 Graphene Biosensor Characterizes Difficult-to-Study MYC Oncoprotein for Cancer Research Using data gathered by Agile R100, a kinetic binding assay system, scientists from Dr. Kim Janda’s laboratory […]

2025 Record Year.
$629M Raised by EvoNexus Portfolio Companies.
Read CEO Rory Moore’s 2025 newsletter
  • About
  • People
  • Partners
  • Portfolio
  • Incubation
  • News
X-twitter Facebook Instagram Linkedin

© 2026 EvoNexus. All rights reserved.